Prostate cancer
Innovative metastatic prostate cancer treatment with 177-Lu-PSMA. Prostate cancer is the most common cancer in older men (over 50) and the second cause of cancer death in
Innovative metastatic prostate cancer treatment with 177-Lu-PSMA. Prostate cancer is the most common cancer in older men (over 50) and the second cause of cancer death in
Get in touch…